June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Synergistic protection from retinal degeneration by Combined stem cell therapies
Author Affiliations & Notes
  • Shaomei Wang
    Biomedical Science at Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, California, United States
    Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, United States
  • Changqing Zhang
    Biomedical Science at Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, California, United States
  • bin lu
    Biomedical Science at Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, California, United States
  • Sergey Girman
    Biomedical Science at Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, California, United States
  • Benjamin Bakondi
    Biomedical Science at Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, California, United States
  • Joshua Saylor
    Biomedical Science at Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, California, United States
  • Zhaohui chen
    Biomedical Science at Cedars-Sinai Medical Center, Heart Institute, Los Angeles, California, United States
    Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Shaomei Wang, None; Changqing Zhang, None; bin lu, None; Sergey Girman, None; Benjamin Bakondi, None; Joshua Saylor, None; Zhaohui chen, None
  • Footnotes
    Support  NIH grant EY020488; Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4550. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Shaomei Wang, Changqing Zhang, bin lu, Sergey Girman, Benjamin Bakondi, Joshua Saylor, Zhaohui chen; Synergistic protection from retinal degeneration by Combined stem cell therapies. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4550.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Neural progenitor cells (NPCs) have been shown effective in preserving both photoreceptors and visual function after subretinal injection into rodent models for retinal degeneration. Our recent studies revealed that a subretinal injection of MSC (MSCSRI) combined with intravenous injection of MSC (MSCIV) into the Royal College of Surgeons (RCS) rats with inherited retinal degeneration offers synergistic protection from retinal degeneration and vision loss. The purpose of this study was to investigate clinical relevant NPCs combined with MSCIV as adjuvant therapy for preserving vision in the RCS rat model for retinal degeneration.

Methods : NPCSRI were performed into the RCS rats at postnatal day (P) 21-23, followed by MSCIV on the next day. Blood samples were collected at the several time points after the treatments. Visual function was examined at P60 and P90. Retinas were collected for histology and proteomic analysis.

Results : Combined NPCSRI and MSCIV enhanced visual function as tested by optokinetic response (OKR) and electroretinography (ERG) compared with NPCSRI alone. Further examination on NPCSRI indicated the combined treatments promoted survival of NPCSRI. Proteomic analysis revealed that quality of photoreceptors, function of retina and engraftment of cells related pathway were up-regulated with MSCIV supplementary; apoptosis of neurons, generation of reactive oxygen species related pathway were down regulated.

Conclusions : Combined stem/progenitor treatments offer enhanced protection from retinal degeneration and vision loss. MSCIV as supporting therapy to modulate host immune response and improve overall host microenvironment may have broader application to the regenerative medicine.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×